Biogen (BIIB) PT Lowered to $236 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja lowered the price target on Biogen (NASDAQ: BIIB) to $236.00 (from $325.00) while maintaining a Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE